# Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis

> **NCT04518540** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 150 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** lipoic acid group
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT04518540
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04518540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04518540, "Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04518540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*